Skip to content

Comparison of platelet rich plasma injection and steroid injection combined with radiofrequency treatment for sacroiliac joint pain

A Prospective Randomized Controlled Trial Comparing Intra- and Peri-Articular Platelet-Rich Plasma Injection with Steroid Injection Combined with Lateral Branch Radio frequency Ablation in the Management of Sacroiliac Joint Pain - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/109927
Enrollment
50
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M533- Sacrococcygeal disorders, not elsewhere classified

Interventions

Intervention1: Platelet Rich Plasma plus Lateral Branch Radiofrequency Ablation: Intra and peri articular autologous platelet rich plasma injection of approximately 3 to 4 ml prepared from patient blo

Sponsors

All India Institute of Medical Sciences (AIIMS), Mangalagiri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 to 70 years with chronic sacroiliac joint pain for more than 3 months, positive provocative tests, failure of conservative treatment, and willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: Coagulopathy, anticoagulant therapy, local or systemic infection, pregnancy, malignancy, severe uncontrolled comorbid illness, prior sacroiliac intervention within 6 months, allergy to study medications, severe psychiatric illness, inability to provide consent.

Design outcomes

Primary

MeasureTime frame
Change in Numerical Rating Scale pain scoreTimepoint: Baseline and 3 months after intervention

Secondary

MeasureTime frame
Change in Oswestry Disability Index scoreTimepoint: Baseline, 1 month, 3 months;Patient Global Perceived Effect scoreTimepoint: Baseline, 1 month, 3 months;Rescue analgesic consumptionTimepoint: During follow up up to 3 months;Procedure-related adverse eventsTimepoint: Immediately post-procedure to 3 months

Countries

India

Contacts

Public ContactDr Samarjit Dey

All India Institute of Medical Sciences Mangalagiri

drsamarjit@aiimsmangalagiri.edu.in7805920791

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026